Why Tilray Stock Skyrocketed 54% Last Week

Here’s why Tilray (TSX:TLRY) stock popped by 54% last week to become the top-performing stock on the TSX.

| More on:

What happened?

The shares of Tilray (TSX:TLRY)(NASDAQ:TLRY) staged a massive rally last week to post their biggest weekly gains since the completion of its Aphria acquisition in May 2021. TLRY stock jumped by a solid 54% in the week ended on March 25 to settle at $10.72 per share — its highest closing level in more than three months. With this, Tilray stock, which was down by 20% a couple of sessions ago, is now trading with 20.2% year-to-date gains.

So what?

While Tilray was the biggest gainer among cannabis stocks last week, the shares of its peers like Aurora Cannabis, Canopy Growth, and Cronos Group also saw strong double-digit gains. While Aurora Cannabis ended the week with 23.5% gains in the week ended on March 25, Canopy Growth and Cronos Group shares popped by about 20.7% and 15.9%, respectively.

This rally in pot stocks on the TSX started on March 24 after a Marijuana Moment report claimed that “the U.S. House of Representatives plans to vote on a bill to federally legalize marijuana for the second time in history.” According to the news report, the House vote on this critically important bill for the marijuana industry is likely to take place this week. Investors’ high hopes from the expected House vote triggered a buying spree in Tilray and other cannabis stocks last week.

Now what?

Tilray is one of the largest cannabis companies in the world by market cap. In January, Tilray revealed that it has achieved $70 million in cost synergies to date from its merger with Aphria. Its leading position in several key cannabis markets could help Tilray post strong top-line growth in the coming years.

That said, if you have been following the cannabis industry for some time, you might already be aware that even a small news or industry update usually makes pot stocks highly volatile. While the latest news about the House vote on the marijuana legalization bill is certainly a big one, its outcome is still unknown. That’s why conservative investors may want to remain cautious before making any positions in Tilray or any other pot stock in the near term, as more related updates could keep them extremely volatile.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool has no position in any of the stocks mentioned. Fool contributor Jitendra Parashar has no position in any of the stocks mentioned.

More on Cannabis Stocks

Worker checks cannabis flower in lab farm greenhouse
Cannabis Stocks

Down an Incredible 99% From All-Time Highs, Is Canopy Growth Stock Worth Buying Now?

Canopy Growth stock remains a high-risk investment in 2025 due to its weak balance sheet and volatile profit margins.

Read more »

money goes up and down in balance
Dividend Stocks

2 Incredibly Cheap Growth Stocks to Buy Now

These two growth stocks are both unbelievably cheap and have significant long-term potential, making them some of the best to…

Read more »

A cannabis plant grows.
Stocks for Beginners

1 Canadian Cannabis Stock Down 57% to Buy Now for Future Growth

Cannabis stocks might seem so 2018, but this one could eventually make a major comeback.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »